HEATHER GOODHILE: Open Payments
NPI 1053823427 · WASHINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 19 payments from 10 companies in 2025. Trend: 2023 $156 · 2024 $197 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 3 | $187 |
| TerSera Therapeutics LLC | 6 | $179 |
| Nalu Medical, Inc. | 1 | $62 |
| Collegium Pharmaceutical, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $40 |
| Averitas Pharma Inc. | 1 | $37 |
| SPR Therapeutics, Inc | 1 | $29 |
| AppliedVR Inc | 1 | $24 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Virtus Pharmaceuticals LLC | 1 | $18 |
Products named: Prialt, General - Pain Management, Intracept, Nalu Neurostimulation System, Belbuca, BOTOX, QUTENZA, SPRINT PNS System.
Industry payments across PA — which companies pay providers there.
